GERD :: New studies reveal that night-time acid reflux can impact sleep

According to results of a survey presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology, nighttime acid reflux, along with some of the less typical manifestations or symptoms of gastroesophageal reflux disease (GERD), is associated with significant sleep impairment.

Colorectal Cancer :: Racial and ethnic differences in colorectal cancer emphasize importance of screening

New research presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology emphasizes the importance of colorectal cancer (CRC) screening among racial and ethnic minorities, who have a higher incidence of colorectal cancer compared to Caucasians. Two studies found more African-Americans had advanced polyps on the right side of the colon than Caucasians, while results from colonoscopy screenings of Latin Americans revealed similarly high risk findings to African-Americans.

Fish :: Consumption of raw fish raises potential health concerns for consumers

Two case studies from Japan presented at the 72nd Annual Meeting of the American College of Gastroenterology point to a potential health problem in the United States, as more Americans consume raw fish in the form of sushi and sashimi. Anisakiasis (round worm) is a human parasitic infection caused by the consumption of raw or undercooked seafood containing Anisakis larvae. Consumers should be aware that while larvae for the parasitic worm Anisakis cannot survive in a human host, the ingested larvae can produce severe intestinal problems warranting a visit to the emergency room.

Colorectal Cancer :: Colorectal cancer screening remains essential for elderly Americans

As people get older, their risk of developing polyps and colorectal cancer increases. Currently, there is no clear evidence or established guideline for the upper age limit for colorectal cancer screening by colonoscopy. Two new studies presented at the American College of Gastroenterology’s 72nd Annual Scientific Meeting suggest continued colorectal cancer screening among healthy elderly Americans.

Irritable Bowel Syndrome :: Bifantis can claim efficacy vs. placebo for IBS symptoms

A new analysis of randomized controlled trials evaluating probiotics in the treatment of irritable bowel syndrome (IBS) has found that Bifantis®, Bifidobacterium infantis 35624, the sole ingredient in Align® (manufactured by Procter & Gamble), is the only probiotic currently able to demonstrate significant improvement in IBS symptoms based upon a properly designed research study.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack